| Year |
Citation |
Score |
| 2022 |
Wang J, Thomas HR, Thompson RG, Waldrep SC, Fogerty J, Song P, Li Z, Ma Y, Santra P, Hoover JD, Yeo NC, Drummond IA, Yoder BK, Amack JD, Perkins B, ... Parant JM, et al. Variable phenotypes and penetrance between and within different zebrafish ciliary transition zone mutants. Disease Models & Mechanisms. 15. PMID 36533556 DOI: 10.1242/dmm.049568 |
0.58 |
|
| 2021 |
Bentley-Ford MR, LaBonty M, Thomas HR, Haycraft CJ, Scott M, LaFayette C, Croyle MJ, Andersen RS, Parant JM, Yoder BK. Evolutionarily conserved genetic interactions between nphp-4 and bbs-5 mutations exacerbate ciliopathy phenotypes. Genetics. PMID 34850872 DOI: 10.1093/genetics/iyab209 |
0.47 |
|
| 2018 |
Chumley P, Zhou J, Mrug S, Chacko BK, Parant JM, Challa AK, Wilson LS, Berryhill TF, Barnes S, Kesterson RA, Bell PD, Darley-Usmar VM, Yoder BK, Mrug M. Truncating PKHD1 and PKD2 mutations alter energy metabolism. American Journal of Physiology. Renal Physiology. PMID 30566001 DOI: 10.1152/Ajprenal.00167.2018 |
0.353 |
|
| 2016 |
Lewis WR, Malarkey EB, Tritschler D, Bower R, Pasek RC, Porath JD, Birket SE, Saunier S, Antignac C, Knowles MR, Leigh MW, Zariwala MA, Challa AK, Kesterson RA, Rowe SM, ... ... Parant JM, et al. Mutation of Growth Arrest Specific 8 Reveals a Role in Motile Cilia Function and Human Disease. Plos Genetics. 12: e1006220. PMID 27472056 DOI: 10.1371/Journal.Pgen.1006220 |
0.411 |
|
| 2016 |
Parant JM, Yeh JR. Approaches to Inactivate Genes in Zebrafish. Advances in Experimental Medicine and Biology. 916: 61-86. PMID 27165349 DOI: 10.1007/978-3-319-30654-4_3 |
0.332 |
|
| 2015 |
Percival SM, Thomas HR, Amsterdam A, Carroll AJ, Lees JA, Yost HJ, Parant JM. Variations in dysfunction of sister chromatid cohesion in esco2 mutant zebrafish reflect the phenotypic diversity of Roberts syndrome. Disease Models & Mechanisms. 8: 941-55. PMID 26044958 DOI: 10.1242/Dmm.019059 |
0.578 |
|
| 2015 |
Crittenden F, Thomas HR, Parant JM, Falany CN. Activity Suppression Behavior Phenotype in SULT4A1 Frameshift Mutant Zebrafish. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 43: 1037-44. PMID 25934576 DOI: 10.1124/dmd.115.064485 |
0.36 |
|
| 2014 |
Thomas HR, Percival SM, Yoder BK, Parant JM. High-throughput genome editing and phenotyping facilitated by high resolution melting curve analysis. Plos One. 9: e114632. PMID 25503746 DOI: 10.1371/Journal.Pone.0114632 |
0.421 |
|
| 2010 |
Parant JM, George SA, Holden JA, Yost HJ. Genetic modeling of Li-Fraumeni syndrome in zebrafish. Disease Models & Mechanisms. 3: 45-56. PMID 20075382 DOI: 10.1242/Dmm.003749 |
0.569 |
|
| 2009 |
Parant JM, George SA, Pryor R, Wittwer CT, Yost HJ. A rapid and efficient method of genotyping zebrafish mutants. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 238: 3168-74. PMID 19890916 DOI: 10.1002/Dvdy.22143 |
0.566 |
|
| 2007 |
Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy ME, Campbell DS, Parant JM, Yost HJ, Kanki JP, Chien CB. The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 236: 3088-99. PMID 17937395 DOI: 10.1002/Dvdy.21343 |
0.457 |
|
| 2004 |
Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, Parant JM, Valentin-Vega YA, Terzian T, Caldwell LC, Strong LC, El-Naggar AK, Lozano G. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell. 119: 861-72. PMID 15607981 DOI: 10.1016/J.Cell.2004.11.006 |
0.336 |
|
| 2004 |
Iwakuma T, Parant JM, Fasulo M, Zwart E, Jacks T, de Vries A, Lozano G. Mutation at p53 serine 389 does not rescue the embryonic lethality in mdm2 or mdm4 null mice. Oncogene. 23: 7644-50. PMID 15361844 DOI: 10.1038/Sj.Onc.1207793 |
0.344 |
|
| 2003 |
Chavez-Reyes A, Parant JM, Amelse LL, de Oca Luna RM, Korsmeyer SJ, Lozano G. Switching mechanisms of cell death in mdm2- and mdm4-null mice by deletion of p53 downstream targets. Cancer Research. 63: 8664-9. PMID 14695178 |
0.31 |
|
| 2003 |
Parant JM, Lozano G. Disrupting TP53 in mouse models of human cancers. Human Mutation. 21: 321-6. PMID 12619119 DOI: 10.1002/Humu.10186 |
0.388 |
|
| 2001 |
Parant J, Chavez-Reyes A, Little NA, Yan W, Reinke V, Jochemsen AG, Lozano G. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nature Genetics. 29: 92-5. PMID 11528400 DOI: 10.1038/Ng714 |
0.365 |
|
| Show low-probability matches. |